As of 2025-10-15, the Relative Valuation of Edgewise Therapeutics Inc (EWTX) is (29.40) USD. This relative valuation is based on P/E multiples. With the latest stock price at 14.70 USD, the upside of Edgewise Therapeutics Inc based on Relative Valuation is -300.0%.
The range of the Relative Valuation is (26.44) - (29.38) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.2x - 20.5x | 20.3x |
| Forward P/E multiples | 18.5x - 23.1x | 20.8x |
| Fair Price | (26.44) - (29.38) | (29.40) |
| Upside | -279.8% - -299.9% | -300.0% |
| Date | P/E |
| 2025-10-08 | -10.73 |
| 2025-10-07 | -10.58 |
| 2025-10-06 | -10.73 |
| 2025-10-03 | -10.94 |
| 2025-10-02 | -10.49 |
| 2025-10-01 | -10.79 |
| 2025-09-30 | -11.34 |
| 2025-09-29 | -11.01 |
| 2025-09-26 | -11.22 |
| 2025-09-25 | -10.41 |
| 2025-09-24 | -11.60 |
| 2025-09-23 | -10.55 |
| 2025-09-22 | -10.56 |
| 2025-09-19 | -9.97 |
| 2025-09-18 | -10.86 |
| 2025-09-17 | -9.71 |
| 2025-09-16 | -9.83 |
| 2025-09-15 | -9.58 |
| 2025-09-12 | -9.95 |
| 2025-09-11 | -10.26 |
| 2025-09-10 | -10.26 |
| 2025-09-09 | -10.31 |
| 2025-09-08 | -10.40 |
| 2025-09-05 | -10.88 |
| 2025-09-04 | -10.22 |
| 2025-09-03 | -10.23 |
| 2025-09-02 | -10.39 |
| 2025-08-29 | -10.03 |
| 2025-08-28 | -10.24 |
| 2025-08-27 | -10.10 |
| 2025-08-26 | -10.21 |
| 2025-08-25 | -10.00 |
| 2025-08-22 | -10.38 |
| 2025-08-21 | -10.22 |
| 2025-08-20 | -9.67 |
| 2025-08-19 | -9.65 |
| 2025-08-18 | -9.79 |
| 2025-08-15 | -9.89 |
| 2025-08-14 | -9.74 |
| 2025-08-13 | -9.60 |
| 2025-08-12 | -9.36 |
| 2025-08-11 | -9.08 |
| 2025-08-08 | -8.86 |
| 2025-08-07 | -9.05 |
| 2025-08-06 | -9.45 |
| 2025-08-05 | -9.60 |
| 2025-08-04 | -9.51 |
| 2025-08-01 | -10.00 |
| 2025-07-31 | -9.97 |
| 2025-07-30 | -9.95 |